Organizational Overview

The Transfusion Medicine Hemostasis Clinical Trial Network is funded through the National Heart, Lung and Blood Institute (NHLBI), a division of the National Institutes of Health (NIH).

The Data Coordinating Center (DCC) plays a key role in developing and facilitating study protocols and is responsible for statistical planning and accumulation of quality data from participating clinical centers. The DCC for the TMH CTN is New England Research Institutes, Inc., www.neriscience.com

There are 17 Core Clinical Centers (some of which are consortia of two or more centers) with cooperative agreements from the NHLBI to participate in the CTN. Additional non-Core Centers may also participate in CTN trials through subcontracts with the DCC.

NHLBI/NIH:

Traci Mondoro, PhD - Project Officer
National Heart, Lung, and Blood Institute; National Institutes of Health
Division of Blood Diseases and Resources
6701 Rockledge Drive, Room 9174
Bethesda, MD 20817
(301) 435-0052, (301) 480-0868 (FAX)
Email: mondorot@nhlbi.nih.gov

Susan Assmann, PhD
New England Research Institutes, Inc.
9 Galen Street, Suite 117
Watertown, MA 02472
(617) 972-3048, (617) 673-9529 (FAX)
Email: sassmann@neriscience.com

TMH Network Steering Committee Chair

M.A. Blajchman, MD, FRCP(C)
Chair, NHLBI  TMH CTN Steering Committee
Professor Emeritus, Departments of Pathology and Medicine
McMaster University
1200 Main St. W., HSC-4N67
Hamilton, ON, Canada L8N 3Z5
(905) 525-9140 Ext. 26276; (905)-527-4866 (FAX)
Email: blajchma@mcmaster.ca